Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Cathartic Colon
Interventions
DRUG

Oral sulfate solution (OSS)

Oral sulfate solution (OSS)

DRUG

2-L PEG/Asc

Low-dose polyethylene glycol plus ascorbic acid (2-L PEG/Asc) COOLPREP is a proprietary name of 2-L PEG/Asc.

Trial Locations (1)

137-040

Seoul St. Mary's Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pharmbio Korea Co., Ltd.

INDUSTRY

lead

Bo-In Lee

OTHER

NCT02761213 - Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid | Biotech Hunter | Biotech Hunter